1. Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS). (14th October 2021) Authors: Eliaz, R; Mengesha, B; Ovdat, T; Iakobishvili, Z; Hasdai, D; Kheifets, M; Klempfner, R; Beigel, R; Kalmanovich, E; Alcalai, R; Levi, A Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗